Chil-Artificial intelligence Lab

Cervical and breast cancer have  of late become a global Problem .In 2018 an estimate of 311000 and 508000 women died globally from cervical and breast cancer respectively.To the sad note ,65% of these death  occur in least developed countries .In Uganda these  two diseases lead to 75% of all cancer death among women . This is  highly attributed to late diagnosis ,a factor highly attributed to  information,Distance,Privacy ,Time  barriers ; we provide E-oncology services like consultation, interpretation of laboratory/kit results, prescription using our AI mobile application, we go on to avail women with  accurate self testing kits that is cervical cancer testing kit that checks for presence of HPV 16/18 and breast cancer self-testing kit that checks for presence of plakoglobin.If this technology is scaled globally,  millions of women will be availed with chance to become oncologists of their own and will never die of cervical or breast cancer

Cancers have become one of  the leading causes of death among human race of recent .According to the World Health Organisation in 2018 Alone, cancer burden raised to 18.1 million new cases and claimed the lives of 9.6 Million people globally .More to that cancer of the cervix and the breast are the leading causes of death among women According to World Health Organisation,Globally more than 800,000 women die of cervical and breast cancer yearly .Unfortunately Two thirds of breast cancer deaths and 9 out of 10 deaths from cervical cancer occur in low- and middle income countries (LMICs).In Uganda alone cervical cancer and breast cancer contribute to more than 60% of all cancer death affecting women.This is highly attributed to long distances between rural and screening centers a factor that hinders women from seeking screening in time .This is  also accompanied by the expensiveness of the Oncology services like consultation ,screening ,treatment ,referral among other factors .These also scare away women to carry out regular and on time  checkup.

Our major focus is every woman who may be having hindrances to access  regular breast and cervical cancer but during the Pilot  and Testing Phase we concentrated on women Living in slums of Uganda and now that we have got approval from several countries ministries of Health(south Sudan,Democratic Republic of Cong,and soon getting certification in South Africa) we  are intending to scale  and reach every woman in slums of cities of Nairobi,Juba,Kisasha and Cape town at a later date).

Our product is divided into two categories ;
1).Self testing Kits ,Under this category we have two type of kits that use Artificial intelligence technology to test Cervical cancer and breast cancer
a.)Cervical cancer Kit-This an artificial intelligence Technology that test the availability of HPV 16 and 18 .A woman inserts the device into her vagina for 3 minutes and the device using high level sensor technology tests for the availability for HPV 16 and 18 which are precursors of cervical cancer .The results are sent to our E-Oncology Mobile Application which using Bluetooth for interpretation .
b) Breast cancer Kit ,this is a smart non infra red   scanner  that uses the sensor technology to determine  the abnormalities in the breasts and also results are sent to the same E-Oncology App for interpretation using the Bluetooth technology .
2).It also involves the E-Oncology Artificial Intelligence Mobile Application that offers our customers with E-Consultation ,analysis of the customer cancer medical history ,guides the customer on how to use the self testing kit(either breast or cervical  )  results interpretation(got directly from self testing kit or partner laboratory ,prescription if need  be ,referral of customers in case of advanced cancer results .

Chil artificial intelligence lab has seen technology being invented by various innovators globally but has always found some missing gap somewhere for instance most of the technology in the breast and cervical oncology sector in Uganda only looks at screening , this leaves a gap in the whole medical procedure where by someone first consults a doctor before a given test is recommended and in this we have invented deployed an AI powered mobile application that offers preliminary procedures like consultation before screening is done .More so even the self testing  technologies available on market cause more false alarm than relief for instance the technologies in breast cancer screening available in Uganda  only checks for presence of tumor and breast abnormalities , a positive result from using such technology makes a woman get so worried forgetting that not all tumors are cancer causing , the same has been seen in cervical cancer self testing technologies on market that merely checks for presence of HPV . Based on this revelation and loopholes on the current system chil has invented the most realistic and accurate self testing kits that checks for HPV 16/18 which are cervical cancer precursors and presence of plakoglobin which are breast cancer precursors. 

Our technology is predominantly made of low memory artificial intelligence where the artificial intelligence system learns from either pre set information or learns from the data input by the user for example our AI mobile application offers services like consultation interpretation of laboratory results, prescription , learning and basing on the information pre designed by our physical oncologists. In addition to the AI our self testing kits use sensor technology to do most of the work for example our cervical cancer self testing kit uses a high level sensor technology to determine the presence of HPV 16 and 18. Lastly our mobile application and the self testing kits are also interconnected using blue tooth technology for information sharing that is if the woman is using the self testing kit that is breast or cervical gets direct interpretation from the application(in their local language) after it receiving it from self testing kit (in ones and zeros)  connection via blue tooth  

Reaserch by Uganda Cancer institute ,has it that more

Chil Artificial Intelligence Lab runs one of the best Indigenous Cancer Laboratories in Uganda and South Sudan and the Profit that is got from these Laboratories is invested back to the mother company to increase the scope of her work. These usually contribute 17% of our revenue

More so we seek for grants and donations from various agencies like the United Nations Development Program /Youth ConneKt Africa ,Government of Uganda,USAID etc  and the Grants got are used purposely for   increasing the scope of this Technology.This contribute to 11% of our revenue.

We sell our services that is the self testing Kits and services offered by the Mobile Application these generate 55% of our revenue.

Chil also seeks loans from our bankers like the United Bank For Africa for puposes of company expansion.These never exceed 1% of the revenue .

Equity is another way chil gets some revenue and these contribute to 6%.

Yearly our directors put back some money into the company and their  contribution add up to 10%  of the company revenue.